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Abstract 
Objectives: To evaluate the effectiveness of an educational intervention on knowledge of cardiovascular disease (CVD) and to 
increase awareness of risk factors among female patients of a community health center with an on-site 340B pharmacy.   
Methods: The program consisted of a 10-minute educational intervention and brief pre-test, post-test, and participant satisfaction 
survey. Adult female patients at the clinic for any provider visit or prescription fill were eligible to participate. Participants met 
individually with a student pharmacist or faculty member and verbally completed the pre-test. The participant received education 
regarding CVD, risk factors, and symptoms of myocardial infarction and were screened for hypertension and/or hyperlipidemia. The 
post-test was then verbally administered.  Participants answered the satisfaction survey privately. Based on individual needs, 
educational materials and information on available pharmacy clinical services were provided.  The university IRB deemed the study 
exempt.  Results: Eighty-four individuals received educational materials and/or a screening test. Of those, 30 women (mean age 46.9 
years) completed the educational intervention. Thirteen (43%) reported smoking; 22 (73%) identified themselves as overweight. 
Fourteen (47%) indicated a preexisting diagnosis of hypertension. Correct responses for 6 of 8 knowledge-based questions were 
statistically significantly improved from pre-test to post-test (p<0.05). Twenty-nine patients (97%) rated the program as “useful” or 
“very useful”.  Conclusion: CVD is the leading cause of death in U.S. women. Data from this program indicate that through screening 
and education, pharmacists and student pharmacists can impact female patients’ knowledge of CVD risk factors. Continued efforts in 
this area may help to reduce the public health burden of CVD.  
 
 
Introduction 
Pharmacists and student pharmacists are becoming 
increasingly engaged in primary and secondary prevention 
efforts aimed to improve the public’s health.  Primary 
prevention aims to prevent or reduce the occurrence of 
disease.   Pharmacists and student pharmacists further 
primary prevention efforts in numerous ways, including 
vaccination programs, needle exchange programs, and 
patient education.  Secondary prevention refers to activities 
directed to detect disease at an early stage.  The many types 
of screening programs implemented by pharmacists and 
student pharmacists are examples of secondary prevention.
1
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A significant public health initiative, Million Hearts
TM
, has 
been recently launched by the U.S. Department of Health and 
Human Services.  The goal of this campaign is to prevent 1 
million heart attacks and strokes over the next 5 years 
through public-private partnerships to empower individuals 
to make heart-healthy choices and to focus on 4 core 
elements of care for those who need treatment.
2
  Pharmacy 
organizations including the American Pharmacists Association 
and the American Association of Colleges of Pharmacy, 
among others, are partnering with the Million Hearts 
campaign and are encouraging pharmacists and student 
pharmacists to become involved.
3,4
  This paper details the 
outcomes of an educational program to raise awareness and 
improve knowledge about cardiovascular disease (CVD) 
among low income women.  The program, titled “Heart-to-
Heart”, was developed and implemented by pharmacy faculty 
and student pharmacists and provides a framework that can 
be replicated or adapted for other programs. 
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Objectives 
The primary objective of this study was to evaluate the 
effectiveness of a 10- minute educational intervention on 
improving knowledge of CVD and to increase the awareness 
of risk factors among female patients of a Federally Qualified 
Health Center (FQHC).  The secondary objective of this study 
was to measure participant satisfaction with the educational 
program.   
 
Methods 
Research Project Setting 
The research project was conducted at Health Partners of 
Western Ohio (previously named Allen County Health 
Partners) located in Lima, Ohio.  Health Partners of Western 
Ohio (HPWO) is funded by the U.S. Department of Health and 
Human Services as a FQHC.  HPWO consists of two health 
centers located in northwest Ohio (Lima and New Carlisle) 
that provide primary healthcare services to indigent patient 
populations, regardless of their ability to pay.  Prescription 
services through various programs (340B competitive pricing, 
Pfizer
®
 Sharing the Care, Astra Zeneca
® 
AZ&ME, and others) 
are available to help meet the patients’ medication needs.  
Pharmacists meet with patients for medication therapy 
management (MTM) and chronic disease management 
through provider referral at both health centers.  Clinical 
services provided by pharmacists include diabetes, 
cholesterol, asthma, chronic obstructive pulmonary disease 
(COPD), and hepatitis C.   
 
Study Design  
The Ohio Northern University (ONU) Institutional Review 
Board approved this study as an exempted research project.  
This prospective study was conducted once a month from 
December 2009 to April 2010 at the Lima health center of 
HPWO.  Potential study participants were eligible for 
inclusion if they were 18 years of age or older, female, and 
currently a patient of HPWO or present at HPWO with a 
friend or family member who was a patient of the clinic.  Any 
male patients interested in the educational program were 
permitted to participate; however, data from male patients 
are not included in the results of this study.  HPWO 
personnel, who include physicians, nurse practitioners, and 
health center support staff, were educated on the program. 
During scheduled appointments, clinic healthcare providers 
encouraged patients to attend the program.  Pharmacists also 
identified potential participants for the study by referring 
patients who picked up prescriptions for CVD. Women in the 
waiting room were also informed of the opportunity to 
participate in the educational program. 
 
The authors designed the pre- and post-tests, 10-minute 
educational script, and participant satisfaction survey.  
Student pharmacists participating in the delivery of this 
pharmacy service attended a seminar where training 
materials outlining the format and objectives of the program 
were distributed.  Also during the training session, students 
were educated about the importance of implementing the 
intervention in a consistent manner and were educated 
about verbal and non-verbal cues to avoid; the students then 
practiced delivering the scripts and pre/post-tests.  The 
students also performed blood pressure checks, which were 
assessed by a faculty member for accuracy.    
 
The pre- and post-tests were adapted from a published cross-
sectional survey developed by pharmacists to assess 
knowledge of CVD among community residents.
5
  The tests 
were then piloted in a group of eleven randomly-selected 
HPWO patients to evaluate face-validity.  The finalized pre-
test (Appendix 1) consisted of eight knowledge-based 
questions that assessed participants’ awareness of  CVD risk 
factors and lifestyle modifications, and 12 questions to collect 
participant characteristics (family history, social history, 
demographics).  The post-test (Appendix 2) was immediately 
administered following the educational intervention, and 
contained the identical knowledge-based questions from the 
pre-test.  
 
An ONU pharmacy faculty member and three to five student 
pharmacists set up the program in a semi-private room of the 
clinic each month. A ratio of one student: one participant was 
utilized during the program, and students verbally 
administered the pre-test before the intervention.     Students 
then provided 10 minutes of scripted information to each 
participant, focusing on the prevention and management of 
CVD.  The program script (Appendix 3) was developed 
utilizing recommendations from the U.S. Preventive Services 
Task Force;
6
 Joint National Committee on Prevention, 
Detection, Evaluation, and Treatment of High Blood Pressure 
(JNC 7);
7
 and the American Heart Association evidence-based 
guidelines for prevention of CVD in women.
8
  The script was 
written at an appropriate literacy level, and the use of 
medical jargon was avoided.  In addition, approaches to 
patient education and counseling about CVD specifically for 
women
9,10
 and ethnically-diverse, low-income women
11
 were 
incorporated.   Educational topics included modifiable and 
non-modifiable risk factors and lifestyle modifications such as 
nutrition, physical activity, and smoking cessation.  
Participants were informed that women may experience one 
or multiple “traditional” (e.g., discomfort or pressure in the 
chest; shortness of breath; pain in one or both arms, the 
upper back, neck, jaw, or stomach) and/or “non-traditional” 
(e.g., nausea and vomiting; breaking out in a cold sweat; 
dizziness or lightheadedness; anxiety) symptoms of a 
myocardial infarction (MI).  Women were also educated 
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about steps to take if experiencing these symptoms (e.g., 
calling 911 immediately but no later than 5 minutes).  Blood 
pressure measurements were taken and recorded on a 
wallet-sized card during the educational session if 
participants voluntarily chose to have it measured.  In 
addition, during two sessions students offered free 
cholesterol screenings (lab panel including total cholesterol, 
LDL, HDL, triglycerides, and glucose).   
 
Following the intervention, students verbally administered 
the post-test.  Participants were then provided additional 
counseling and educational pamphlets (on topics such as 
hypertension, stroke, diabetes, cholesterol management, and 
smoking cessation) that targeted the participant’s identified 
risk factors.  Participants were also referred to other 
pharmacy services at HPWO, such as smoking cessation, if 
appropriate. The satisfaction survey developed by the 
authors (Appendix 4) was completed independently by each 
participant to elicit more frank feedback; the form was sealed 
in an envelope before being submitted.   
 
Participants were numbered sequentially as they enrolled 
into the study.  Pre-test, post-test, and satisfaction surveys 
were numbered to facilitate matching and allowed for the 
assessment of change in knowledge; these numbers were not 
linked to identifiable information.  All test and survey data 
were collected via Scantron
® 
computer scan forms.  Data 
were scanned into an Access 2003
®
 database.  Microsoft Excel 
2007
®
, Microsoft Access 2007
® 
and Minitab Version 15
®
 were 
utilized to calculate all statistical analyses. Descriptive 
statistics were calculated for multiple parameters. The paired 
t-test was utilized to assess whether differences in pre-test 
results and post-test results were statistically significant.  
Alpha was set a priori at <0.05. 
 
Results 
Eighty-four individuals participated in some aspect of the 
program.  Forty-four received only educational materials or a 
screening test due to time constraints.  Forty participants 
initiated the educational intervention; 10 were omitted from 
the final analysis due to incompletion of the entire 
intervention (n=7) or male sex (n=3). Therefore, 30 total 
women were included in the analysis. 
 
Baseline demographics and clinical characteristics of the 30 
women who completed the educational intervention are 
outlined in Table 1. Most reported risk factors for CVD, and 
many had two or more risk factors and/or co-morbidities. 
 
Test Scores: A perfect score on both the pre-test and post-
test was 34 points.  Individual and mean pre- and post-test 
scores are displayed in Figure 1. The mean pre-test score per 
participant = 25.7 +/- 4.9 points (range 15-32 points). The 
mean post-test score per participant = 30.3 +/- 2.4 points 
(range 25-34 points).  There was a statistically significant 
increase in mean test scores between the pre- and post-test 
(p<0.001).   
 
Table 2 shows the difference in the mean pre- and post-test 
scores for each question on the pre- and post-test.  There was 
an improvement in post-test scores for each question. 
Correct responses to six questions were statistically 
significant for improved post-test scores: identification of 
foods high in sodium; identification of a “healthy” blood 
pressure reading; identification of a “healthy” total 
cholesterol value; identification of MI warning signs; 
identification of correct action to take if experiencing MI 
symptoms; and identification of risk factors for CVD in 
women. 
 
Test Scores for Identification of Warning Signs of MI: Figure 2 
illustrates the changes in pre- vs. post-test scores for correct 
identification of MI warning signs in women. The number of 
correct responses on the post-test was greater than the pre-
test for every sign or symptom with the exception of feeling 
faint which dropped from 23 to 21. 
 
Relationships between Disease States and Demographics vs. 
Changes in Total Scores: No changes were demonstrated 
when the data was analyzed comparatively for the presence 
of co-morbidities and cardiovascular risk factors in relation to 
changes in total test scores. 
 
Satisfaction:  All participants privately completed the 
satisfaction survey (n=30).  Satisfaction data demonstrated 
that 22 participants (73.3%) learned cardiovascular risk 
factors of which they were previously unaware. Twenty-nine 
(97%) participants rated the program to be either useful or 
very useful and indicated they would recommend the 
program to others.  Twenty-five (83%) participants planned to 
discuss their results with their physician.  
 
Discussion 
The Million Hearts
TM
 campaign has made raising awareness 
and providing education about CVD a priority for healthcare 
professionals to improve their patients’ health.  CVD is the 
leading cause of death for men and women in the United 
States (U.S.).,
12
 and the lifetime incidence of CVD is nearly 1 
in 2 women.
8
  However, data have shown that 55% of women 
know that CVD is the leading cause of death for both sexes in 
the U.S., and nearly 40% do not perceive themselves to be at 
risk.
10
  Twenty-five percent of women surveyed indicated that 
their healthcare provider had not emphasized that heart 
health was important, and 20% relayed that they had not 
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been clearly told how they can change their risk status.
10
  
Data indicating that many women may not realize that they 
are at risk for CVD has led to the development of programs 
such as “The Heart Truth
®
”
13
  and “Make the Call: Don’t Miss 
a Beat”
14
 to personalize and deliver information on these 
risks specifically to women.  On a local level, the need for 
access to free information and screening for CVD among 
female residents of Lima, Ohio (where 30.3% of the residents 
have incomes below the federal poverty level
15
) spurred the 
development of this program.   
 
The data from the Heart-to-Heart program support recently 
published studies showing that pharmacists and/or student 
pharmacists can have a positive impact on patient 
assessment of CVD and satisfaction with such services in 
clinic, community pharmacy, and community center settings 
in the United States.
5,16-19
  A strength of the Heart-to-Heart 
program was the pre- and post-test design, as these previous 
studies did not collect participant knowledge both before and 
after the intervention.  Another strength was the student 
training session to review the standardized script and 
pre/post-test materials, which helped to ensure consistency 
in the delivery of the program.  The fact that women received 
specific, personalized information and recommendations at 
the conclusion of the session was another benefit of the 
program design.  Based on risk factors identified during the 
program, women received specific referrals and /or patient 
education materials after they had taken the post-test.  
 
Limitations to this study include the small sample size and 
voluntary participation; participants may not be 
representative of the overall female clinic population due to 
self-selection bias. The data on intention to follow-up with 
physician was self-reported; the design of the study did not 
allow for tracking of patient appointments or for the 
evaluation of long-term retention of knowledge.  Finally, 
another limitation to the study design is the lack of a control 
group.   
 
Programs like Heart-to-Heart can be incorporated into 
introductory or advanced pharmacy practice experiences 
(IPPE or APPE), providing opportunities for student 
pharmacists to be exposed to primary and secondary 
prevention concepts and to impact patient knowledge and 
assessment.  Public health is emphasized in pharmacy 
education,
20,21
 and these types of programs enable student 
pharmacists to augment their didactic education with 
experiential learning. Additionally, the implementation of 
these programs allows for further study of the impact of such 
interventions in larger numbers of women in different patient 
care settings.  Future studies may be designed to collect 
information on long-term knowledge retention, behavior 
change, and/or clinical outcomes among participants of the 
educational intervention to provide insight regarding its 
clinical significance.  Through education and screening for 
CVD, pharmacists and student pharmacists can fulfill an 
important role in public health activities while advancing the 
pharmacy profession’s provision of patient-centered care.    
 
Conclusion 
CVD is the leading cause of death in U.S. women. The data 
from this program indicate that through screening and 
education, pharmacists and student pharmacists can impact 
female patients’ knowledge of cardiovascular risk factors.  
Additionally, most program participants found this type of 
program to be useful and would recommend it to others. 
Continued efforts in this area may help to reduce the public 
health burden of CVD in women. 
 
References 
1. Farris KB, Johnson KA.  Pharmacists in public health: 
it's a good start! J Am Pharm Assoc. 2010;50:128-
130. 
2. Centers for Disease Control and Prevention. Million 
Hearts.
TM   
Accessed at 
http://millionhearts.hhs.gov/index.html, April 26, 
2012.   
3. New public-private sector initiative aims to prevent 1 
million heart attacks and strokes in five years. U.S. 
Department of Health and Human Services Press 
Office, September 13, 2011. Accessed at 
http://www.hhs.gov/news/press/2011pres/09/2011
0913a.html, April 26, 2012.  
4. New Million Hearts
TM
 tools announced by partners. 
Centers for Disease Control and Prevention press 
release, November 3, 2011.  Accessed at 
http://millionhearts.hhs.gov/docs/MH_Partners_Pre
ss_Release_11-3-2011.pdf, April 26, 2012.    
5. Mooney LA, Franks AM. Evaluation of community 
health screening participants’ knowledge of 
cardiovascular risk factors. J Am Pharm Assoc 
2009;49(4):529-37.  
6. The Pocket Guide to Clinical Preventive Services, 
2010-11. Recommendations of the US Preventive 
Services Task Force. Agency for Healthcare Research 
and Quality.  Accessed at 
http://www.ahrq.gov/CLINIC/uspstfix.htm#pocket, 
December 10, 2009. 
7. The Seventh Report of the Joint National Committee 
on Prevention, Detection, Evaluation, and Treatment 
of High Blood Pressure 2004.  Accessed at 
http://www.nhlbi.nih.gov/guidelines/hypertension/j
nc7full.pdf, April 26, 2012 
Student Project PHARMACY PRACTICE 
 
http://z.umn.edu/INNOVATIONS                         2012, Vol. 3, No. 2, Article 77                         INNOVATIONS in pharmacy   5 
 
8. Mosca L, Banca CL, Benjamin EJ, et al. Evidence-
based guidelines for cardiovascular disease 
prevention in women: 2007 update (American Heart 
Association Guidelines). J Am Coll Cardiol. 
2007;49:1230-1250. 
9. Mosca L, Mochari-Greenberger H, Dolor RJ, et al. 
Twelve-year follow-up of American women's 
awareness of cardiovascular disease risk and barriers 
to heart health. Circ Cardiovasc Qual Outcomes. 
2010;3:120-127. 
10. Mosca L, Mochari H, Christian A, et al. National study 
of women’s awareness, preventive action, and 
barriers to cardiovascular health. Circulation. 
2006;113:525-534. 
11. Gettlemen L, Winkleby MA.  Using focus groups to 
develop a heart disease prevention program for 
ethnically diverse, low-income women. J Comm 
Health. 2000; 25(6): 439-453. 
12. Centers for Disease Control and Prevention.  Leading 
causes of death in females, United States, 2007. 
Accessed at http://www.cdc.gov/women/lcodc, April 
26, 2012. 
13. Office on Women’s Health. The Heart Truth.
® 
 
Accessed at http://www.womenshealth.gov/heart-
truth/about-us/#b, April 26, 2012. 
14. Office on Women’s Health. Make the call. Don’t miss 
a beat. Accessed at 
http://www.womenshealth.gov/heartattack/, April 
26, 2012. 
15. U.S. Census Bureau. State and county quick facts, 
Lima (city), Ohio. Accessed at 
http://quickfacts.census.gov/qfd/states/39/3943554
.html, April 26, 2012. 
16. Miller SW, Darsey E, Heard TJ, et al. Outcomes of a 
multidisciplinary partnership to improve cardiac 
wellness: an opportunity for pharmacists. Consult 
Pharm. 2010;25:105-116. 
17. Olenak, JL, Calpin M. Establishing a cardiovascular 
health and wellness program in a community 
pharmacy: screening for metabolic syndrome. J Am 
Pharm Assoc. 2010;50:32-36. 
18. Garrison GD, Lubowski TJ, Miller SM, et al. Multi-site 
heart disease risk assessment service provided by 
pharmacy students.  Am J Pharm Educ. 
2010;74(3):41. 
19. Liu YF, Mentele LJ, McDonough RP. Community 
pharmacist assessment of 10-year risk of coronary 
heart disease for union workers and their 
dependents.  J Am Pharm Assoc. 2008;48:515-517. 
20. Accreditation Council for Pharmacy Education. 
Accreditation standards and guidelines: Professional 
degree program in pharmacy leading to the doctor 
of pharmacy degree. Accessed at www.acpe-
accredit.org/standards/default.asp, April 26, 2012. 
21. Center for the Advancement of Pharmaceutical 
Education. 2004 educational outcomes.  Accessed at 
http://www.aacp.org/resources/education/Docume
nts/CAPE2004.pdf, April 26, 2012.  
 
 
 
 
 
 
 
 
 
  
Student Project PHARMACY PRACTICE 
 
http://z.umn.edu/INNOVATIONS                         2012, Vol. 3, No. 2, Article 77                         INNOVATIONS in pharmacy   6 
 
Appendix 1 – Pre-Test 
 
Knowledge Questions 
How much do you feel you know about risk factors for heart disease? 
       A little   
       Some  
        A lot 
 
Which of the following foods are high in sodium? Please mark all that apply. 
       fresh vegetables        fresh fruit         canned soup  
        frozen dinners         potato chips                     lean meat  
 
Which of the following foods has high fat/cholesterol content? Please mark all that apply. 
       biscuits       hamburger               cheese 
       french fries                      plain turkey sandwich              skim milk 
 
How many servings of fruits and vegetables should a person have in one day? Please choose one answer. 
       0 (not necessary to eat fruits or vegetables every day) 
       at least 1-2 
       at least 3-5 
 
What is considered a “healthy” blood pressure reading? Please choose one answer 
       70/40                        120/80   
       150/90         160/100        Don’t know / Not sure 
 
A “healthy” fasting (haven’t eaten recently) total cholesterol is: Please choose one answer 
       Less than 50                       Less than 100          Less than 200 
       Less than 400         Don’t Know / Not Sure  
 
As a woman, which of the following warning signs of a heart attack should you watch for? Please mark all that apply. 
       Chest pain or discomfort             Anxiety     
       Pain in the arm, back, neck, jaw, or stomach                       Trouble sleeping 
        Feel unusually tired and weak        Shortness of breath (feeling like you can’t get enough air) 
       Nausea     
       Breaking into a cold sweat                     
       Feeling faint or woozy 
 
If you think you have any symptoms of a heart attack, what should you do? (choose one answer) 
       Call 911 immediately but no later than 5 minutes 
       Call your doctor immediately but no later than 5 minutes 
       Wait to see if the symptoms go away before calling for help 
 
Which condition(s) increase a woman’s risk for heart disease? Please mark all that apply. 
       High blood pressure            Heartburn                      Age over 55 years 
       Diabetes           Family history     Lack of activity 
       High cholesterol          Smoking                     Obesity/overweight 
 
Demographic Questions  
Why are you at the clinic today? (Please mark all that apply) 
       to see a doctor           pharmacy 
       to see a dentist           Other – specify _______________ 
       to take a family member for an appointment 
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Other than during pregnancy, have you ever been told by a doctor, nurse, or other healthcare provider that you have 
hypertension, also called high blood pressure? 
       Yes   
        No   
        I’ve been told I have borderline high blood pressure (also called pre-hypertensive)  
        I don’t know or I’m not sure 
 
Other than today, about how long has it been since you last had your blood pressure checked by a healthcare provider? 
       Never  
       Less than 1 year  
       Between 1 – 2 years 
       Between 2 – 5 years  
       More than 5 years 
       I don’t know or I’m not sure 
 
Are you currently taking prescription medication for high blood pressure? 
       Yes   
       No   
        I don’t know or I’m not sure 
 
Other than during pregnancy, have you ever been told by a doctor or other healthcare provider that you have diabetes or 
high blood sugar? 
        Yes  
        No  
        I’ve been told I have borderline diabetes or pre-diabetes  
       I don’t know or I’m not sure 
 
Have you ever been told by a doctor, nurse, or other health professional that your blood cholesterol is high? 
       Yes 
        No   
       I don’t know or I’m not sure 
 
Including living and deceased, was your father, mother, sisters or brothers, ever told by a health professional that they had 
heart disease (including a heart attack or stroke)? 
       Yes   
       No  
       I don’t know or I’m not sure 
 
Do you currently smoke or use tobacco products? 
       Yes   
       No  
IF NO, 
Have you ever smoked?   
       Yes         No  
IF YES, 
How long ago did you quit smoking?   _____ months 
 
Do you consider yourself now to be: 
       Overweight    
        Underweight 
       About the right weight    
       don’t know or I’m not sure 
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How old are you today? _____ years 
 
{Note to interviewer: record the patient’s sex– do not ask unless necessary} 
Patient’s sex  
       Male  
       Female   
 
Which one or more of the following would you say is your race or ethnicity? (Mark all that apply) 
       White  
       Black or African American  
       Hispanic 
       Asian 
       Other [specify] ______________________ 
 
What is the highest grade or year of school you completed? Please choose one answer. 
       Never attended school or only attended kindergarten 
        Elementary school (grades 1 through 8) 
        Some high school 
        High school graduate 
        Some college or technical school 
        College graduate 
        Graduate or Professional School (Masters, Doctorate, or Professional  Degree) 
 
Reference: Mooney LA, Franks AM. Evaluation of community health screening participants’ knowledge of cardiovascular risk 
factors. J Am Pharm Assoc 2009;49(4):529-37. 
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Appendix 2 – Post-Test 
 
Knowledge Questions 
How much do you feel you know about risk factors for heart disease? 
       A little   
       Some  
       A lot 
 
Which of the following foods are high in sodium? Please mark all that apply. 
       fresh vegetables         fresh fruit           canned soup  
       frozen dinners                   potato chips                       lean meat  
 
Which of the following foods has high fat/cholesterol content? Please mark all that apply. 
       biscuits       hamburger              cheese 
       french fries                      plain turkey sandwich             skim milk 
 
How many servings of fruits and vegetables should a person have in one day? Please choose one answer. 
       0 (not necessary to eat fruits or vegetables every day) 
       at least 1-2 
       at least 3-5 
 
What is considered a “healthy” blood pressure reading? Please choose one answer 
       70/40                        120/80   
       150/90         160/100        Don’t know / Not sure 
 
A “healthy” fasting (haven’t eaten recently) total cholesterol is: Please choose one answer 
       Less than 50         Less than 100          Less than 200 
       Less than 400         Don’t Know / Not Sure  
 
As a woman, which of the following warning signs of a heart attack should you watch for? Please mark all that apply. 
       Chest pain or discomfort       Anxiety    
       Pain in the arm, back, neck, jaw, or stomach    Trouble sleeping 
       Feel unusually tired and weak                                   Shortness of breath (feeling like you can’t get enough air) 
       Nausea           
       Breaking into a cold sweat                     
       Feeling faint or woozy 
 
If you think you have any symptoms of a heart attack, what should you do? (choose one answer) 
       Call 911 immediately but no later than 5 minutes 
       Call your doctor immediately but no later than 5 minutes 
       Wait to see if the symptoms go away before calling for help 
 
Which condition(s) increase a woman’s risk for heart disease? Please mark all that apply. 
       High blood pressure             Heartburn                      Age over 55 years 
       Diabetes             Family history                     Lack of activity 
       High cholesterol            Smoking                                     Obesity/overweight 
 
Reference: Mooney LA, Franks AM. Evaluation of community health screening participants’ knowledge of cardiovascular risk 
factors. J Am Pharm Assoc 2009;49(4):529-37. 
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Appendix 3 – Educational Program/Script 
#1)  Introduce self 
Hi, my name is ____________ and I am a pharmacy student at Ohio Northern University.  We are working on this project to find 
out how much patients know about heart disease and how it affects their life.  When the project is finished, we will find out if 
patients do or do not have a good understanding of heart disease; this will help us educate more patients in the future.  First I 
will give you a survey; I will read it to you and I want you to answer the questions as best as you can.  The survey is completely 
voluntary, and you may end the survey at any time without penalty.  We are not collecting your name; any information obtained 
in the survey will be confidential and you will never be identified. 
#2)  Administer pre-test   
Read to participant and record answers on pre-test 
#3)  Ask to take participant’s blood pressure   
If participant declines, move onto next step. 
Take blood pressure.  Record reading on card and give to participant.   
Your blood pressure reading is ________.  This is considered as very high (≥140/90)/ a little high (121-139/81-99)/ normal 
(120/80 or below), but we cannot diagnose you.  Please be sure to share this piece of paper with your doctor, and he or she will 
tell you if there is anything you need to do.   
For participants with diabetes, encourage them that their blood pressure should be below 130/80 
In the event a participant’s blood pressure exceeds 180/110 or is symptomatic (chest pain, heart palpitations, short of breath, 
dizzy, sweating) stop immediately and find a faculty member. 
#4)  Provide educational intervention
1-6
 
Heart disease is important for women to learn more about because 1 in 2 women will develop heart disease sometime in her 
life.  There are things that women may do that increase their chances of developing heart disease.  These include: being 
overweight, unhealthy eating habits, smoking, having high blood pressure, high cholesterol and high blood sugar. 
There are also some things women can’t change, but it is very important to know that it may impact whether or not someone 
develops heart disease. 
o Age  
o You cannot change your age and just being over the age of 55 increases your risk of developing a heart 
problem. 
o Family history 
o You also cannot change your family history and if your parents, grandparents, brothers and sisters, or even 
your children have ever been diagnosed with heart disease, your risk for developing it is greatly increased. 
Fortunately, there are things you can change 
o First is, nutrition and weight  
o Maintaining a healthy weight is very important because being overweight greatly increases your risk of 
developing heart disease. 
o Eating 3-5 servings (1 serving is about ½ cup) of fruits and vegetables every day can help you maintain a 
healthy weight and keep your body healthy. 
o Avoid eating a lot of salt.  This can be done by not using the salt shaker to salt food at mealtime and avoiding 
foods such as canned soup, frozen dinners and potato chips. 
o Try to limit foods that are high in fat in order to keep your cholesterol low.  Avoid foods such as: French fries, 
biscuits, hamburgers and donuts.  
o Second is, activity 
o Try to exercise for about 30 minutes 3-4 times per week.   
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o Even a quick walk around the block every day or taking the stairs instead of the elevator can help your heart! 
o Talk to your doctor before any starting any major changes to your daily activity level. 
o Third is, blood pressure   
o Try to keep your blood pressure at or below the normal level of 120/80 in order to reduce your risk for 
developing heart problems. 
o Next is, cholesterol   
o Try to keep your total cholesterol at or below the normal level of 200 mg/dL to help protect your heart.  There 
are two types of cholesterol:  good cholesterol, HDL and bad cholesterol, LDL.   
o You also want to manage your blood sugar  
o It is very important to keep your blood sugar controlled, especially if you have diabetes, in order to keep your 
body healthy. 
o Last is, smoking.   
o If participant DOES NOT currently smoke: 
 I’m happy to hear that you do not smoke, because smoking increases the chances of developing heart 
disease. 
 Be sure to avoid smoking in the future as well. 
o If participant DOES currently smoke: 
 Quitting smoking is the best thing you can do for your health.   
 It is especially important not to smoke if you take birth control pills! 
You should recognize signs/symptoms of a heart attack and know what to do.  By taking the right action, it may save your life or 
help reduce long-term damage. 
o Signs/symptoms of heart attack   
o The signs of a heart attack can be different in women than in men. While men often have chest pain or 
pressure, women may or may not experience chest pain during a heart attack. There are a number of signs of 
a heart attack that are more likely to occur in women and these are: discomfort or pressure in the chest; pain 
in one or both arms, the upper back, neck, jaw, or stomach; nausea and vomiting; breaking out in a cold 
sweat; dizziness or lightheadedness; anxiety; trouble breathing or shortness of breath; and pale or clammy 
skin. 
o What to do – call 911 immediately 
o Do not wait longer than 5 minutes.  Call 911 directly rather than your doctor’s office. 
o It is so important to be informed about your health, especially when it comes to your heart!  Taking steps today in 
order to reduce your risk can help you live a much healthier life in the years to come.   
#5)  Administer post-test   
Read to participant and record answers on post-test 
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#6)  Based on participant’s risk factors listed below, provide the appropriate educational materials and information regarding 
referrals (ex:  clinic services, Ohio Tobacco Quit Line, etc) 
 Participant has high blood pressure based on reading 
 Participant is overweight/obese 
 Participant smokes 
 Participant is currently taking medications for blood pressure or diabetes 
 Participant is over 50 years old  
#7)  Give satisfaction survey and envelope and explain how to complete it  (Form labeled Satisfaction Questions)   
Have participant complete the form in the room before she leaves.  Take participant to separate area of room; be sure to give 
her privacy.  Instruct the participant to put the form into envelope and seal it before turning it in. 
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Appendix 4 - Satisfaction Questions 
 
Did today’s program identify any risk factors for heart disease that you were not aware of before?   
 
  No   
  Yes   
  I don’t know or I’m not sure 
 
Do you plan to talk to a doctor to follow up on what you learned today? Please choose one answer. 
 
  No   
  Yes, I will do this today  
  Yes, I will do this within 1-3 months 
  Yes, I will do this but it will take longer than 3 months 
  I don’t know or I’m not sure 
 
How useful was today’s program for increasing your understanding of each of your risk factors for heart disease? Please 
choose one answer. 
 
  Not useful   
  Somewhat useful  
  Useful  
  Very useful 
 
Would you recommend this program to a friend or family member? 
 
  No   
  Yes   
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Figure 1.  Individual and Mean Pre- and Post-Test Scores 
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Figure 2.  Pre- vs Post-Test Comparison of Correct Identification of Myocardial Infarction (MI) Warning Signs in Women 
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Table 1. Characteristics of Study Participants (N=30) 
 
Parameter Number (%)
a
 
Sex Female 30 (100) 
Race/Ethnicity 
Caucasian 18 (60) 
Black  10 (33) 
Hispanic 0 (0) 
Asian 0 (0) 
Other 1 (3) 
Multiple choices selected 1 (3) 
Self-reported 
cardiovascular 
disease risk factors
b
 
Overweight 22 (73) 
Family history of heart disease 18 (60) 
Hypertension 14 (47) 
Smoking 13 (43) 
Antihypertensive medication 12 (40) 
Hypercholesterolemia 10 (33) 
Diabetes 7 (23) 
Education 
Some high school 7 (23) 
High school  graduate 10 (33) 
Some college 8 (27) 
College graduate 3 (10) 
Graduate/professional school 1(3) 
No response 1 (3) 
 Mean+ Standard 
Deviation  
(Range) 
       Age (yrs) 46.9 + 14.1                    
(18-78) 
a. Total percentage may not equal 100% due to rounding 
b. Total percentage exceeds 100% as some participants reported  > 2 risk factors 
Table 2.  Score Summary By Individual Question (N=30) 
 
Question Perfect Score 
for Question 
Mean Pre-
Test Score 
Mean Post-
Test Score 
Change in Mean 
Score
a
 
p value
b
 
High sodium foods 6 5.40 5.76 0.36   0.025* 
High fat foods 6 5.13 5.33 0.20   0.20 
Recommended number of servings of 
fruits/vegetables per day 
1 0.66 0.86 0.20   0.056 
Healthy blood pressure reading 1 0.76 1.00 0.24   0.006* 
Healthy total cholesterol reading 1 0.26 0.93 0.67 <0.001* 
Myocardial infarction (MI) warning 
signs in women 
9 5.93 7.30 1.37   0.007* 
Action if MI symptoms 1 0.86 1.00 0.14   0.043* 
Risk factors for cardiovascular disease 
in women 
9 6.70 8.13 1.43   0.003* 
a. Calculated by Mean Post-Test Score minus Mean Pre-Test Score 
b. Calculated by paired t-test; asterisk (*) indicates statistical significance 
